Unichem Laboratories surged 4.8% to Rs 239.10 at 10:31 IST on BSE after net profit spurted 897.1% to Rs 20.54 crore on 15.6% growth in net sales to Rs 303.93 crore in Q3 December 2015 over Q3 December 2014.
The result was announced on Saturday, 23 January 2016.Meanwhile, the S&P BSE Sensex was up 162.42 points or 0.66% at 24,598.08.
On BSE, so far 60,000 shares were traded in the counter as against average daily volume of 22,278 shares in the past one quarter. The stock hit a high of Rs 245.90 and a low of Rs 238 so far during the day. The stock had hit a record high of Rs 334 on 6 October 2015. The stock had hit a 52-week low of Rs 174 on 8 June 2015. The stock had underperformed the market over the past one month till 22 January 2016, sliding 14.15% compared with Sensex's 4.51% fall. The scrip had also underperformed the market in past one quarter, declining 20.52% as against Sensex's 10.45% fall.
The small-cap company has equity capital of Rs 18.16 crore. Face value per share is Rs 2.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world. In India, the company is a leader in niche therapy areas of cardiology, neurology, orthopedics and anti-infectives. The company has strong skills in product development, process chemistry and manufacturing of complex APIs as well as dosage forms.
Powered by Capital Market - Live News
